PROVINGS AND CLINICAL OBSERVATIONS WITH HIGH POTENCIES

By CHARLES WILLIAMS

CHAPTER 1 NATIONAL REGISTRY OF DRUG-INDUCED OCULAR SIDE EFFECTS CHAPTER 2 OCULAR DRUG DELIVERY AND TOXICOLOGY CHAPTER 3 METHODS FOR EVALUATING DRUG-INDUCED VISUAL SIDE EFFECTS CHAPTER 4 ANTI-INFECTIVES CHAPTER 5 DRUGS AFFECTING THE CENTRAL NERVOUS SYSTEM CHAPTER 6 DRUGS AFFECTING THE AUTONOMIC NERVOUS SYSTEM CHAPTER 7 ANALGESICS, NARCOTIC ANTAGONISTS, AND DRUGS USED TO TREAT ARTHRITIS CHAPTER 8 DRUGS USED IN ANESTHESIA CHAPTER 9 GASTROINTESTINAL DRUGS CHAPTER 10 CARDIAC, VASCULAR, AND RENAL DRUGS CONTENTS CHAPTER 11 HORMONES AND DRUGS AFFECTING HORMONAL MECHANISMS CHAPTER 12 DRUGS AFFECTING BLOOD FORMATION AND COAGULABILITY CHAPTER 13 HOMEOSTATIC AND NUTRIENT DRUGS CHAPTER 14 DRUGS USED TO TREAT ALLERGIC AND NEUROMUSCULAR DISORDERS CHAPTER 15 ONCOLYTIC DRUGS CHAPTER 16 HEAVY METAL ANTAGONISTS AND MISCELLANEOUS DRUGS CHAPTER 17 DRUGS USED IN THE MANAGEMENT OF HUMAN IMMUNODEFICIENCY VIRUS/ACQUIRED IMMUNODEFICIENCY SYNDROME CHAPTER 18 DRUGS USED IN OPHTHALMOLOGY CHAPTER 19 HERBAL MEDICINE– AND DIETARY SUPPLEMENT–INDUCED OCULAR SIDE EFFECTS